This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

Sponsored by HoHo Biotech

About this trial

Last updated 5 years ago

Study ID

IRB-B202105106

Status

Unknown

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

20 to 80 Years
All Sexes

Not accepting

Healthy Volunteers

Trial Timing

Ended 4 years ago

What is this trial about?

The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the safety and possible efficacy of hydrogen supplements in different formula and dose exposures for a clinical study in rheumatologic patients. Patients will receive a different dosage of either hydrogen capsules, hydrogen gas or hydrogen-rich water with their conventional treatment for a month. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.

What are the participation requirements?

Inclusion Criteria

* Age 20 to 80

* Able to compliant with the protocol

* Able to return to the hospital regularly

Exclusion Criteria

* Pregnancy

* Expected pregnancy